e-learning
resources
2017
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Lung microbiome and host immune tone in subjects with idiopathic pulmonary fibrosis treated with inhaled interferon-?
Jing Wang, Melissa Lesko, Michelle H. Badri, Bianca C. Kapoor, Benjamin G. Wu, Yonghua Li, Gerald C. Smaldone, Richard Bonneau, Zachary D. Kurtz, Rany Condos, Leopoldo N. Segal
Source:
ERJ Open Res, 3 (3) 00008-2017; 10.1183/23120541.00008-2017
Journal Issue:
July
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Jing Wang, Melissa Lesko, Michelle H. Badri, Bianca C. Kapoor, Benjamin G. Wu, Yonghua Li, Gerald C. Smaldone, Richard Bonneau, Zachary D. Kurtz, Rany Condos, Leopoldo N. Segal. Lung microbiome and host immune tone in subjects with idiopathic pulmonary fibrosis treated with inhaled interferon-?. ERJ Open Res, 3 (3) 00008-2017; 10.1183/23120541.00008-2017
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Muscle energy techniques for COPD patients: Effects on pulmonary function and activities of daily living
Related content which might interest you:
Microbes mediated host innate immune response in idiopathic pulmonary fibrosis
Source: International Congress 2016 – Molecular targets in pulmonary disease
Year: 2016
Pulmonary and systemic cellular immune response network in patients with mild-moderate COPD
Source: International Congress 2017 – Systemic and airway biomarkers
Year: 2017
Inhalation therapy of interferon-gamma in patients with idiopathic pulmonary fibrosis
Source: Eur Respir J 2005; 26: Suppl. 49, 266s
Year: 2005
Evasion of COPD in smokers: at what price?
Source: Eur Respir J 2012; 39: 1298-1303
Year: 2012
COPD is associated with reduced pulmonary interstitial expression of pentraxin-3
Source: Eur Respir J 2012; 39: 830-838
Year: 2012
Pulmonary and systemic inflammatory response in patients with pulmonary infections receiving long-term glucocorticoid therapy
Source: Eur Respir J 2002; 20: Suppl. 38, 15s
Year: 2002
The inflammatory cell landscape in the lungs of patients with idiopathic pulmonary arterial hypertension
Source: Eur Respir J, 51 (1) 1701214; 10.1183/13993003.01214-2017
Year: 2018
Local immune protection mechanisms during bacterial infection of the airways in patients with interstitial lung diseases
Source: Annual Congress 2009 - Mechanisms of infection: what's new?
Year: 2009
Anti-fibrotic role of inhaled interferon-γ in idiopathic pulmonary fibrosis
Source: International Congress 2015 – IPF: clinical aspects
Year: 2015
Epidermal growth factor receptor-mediated innate immune responses and their roles in airway diseases
Source: Eur Respir J 2008; 32: 1068-1081
Year: 2008
The pulmonary microbiome and immunological activity in IPF patients.
Source: Virtual Congress 2020 – Translational aspects of idiopathic pulmonary fibrosis
Year: 2020
Does apoptosis evasion only affect fibroblasts from idiopathic pulmonary fibrosis?
Source: Annual Congress 2013 –Cell signalling and inflammation: what's new in 2013?
Year: 2013
Mechanisms of impaired anti-bacterial Th1 responses in patients with chronic obstructive pulmonary disease
Source: International Congress 2018 – Understanding the immunopathology that underlies airway obstructive diseases
Year: 2018
Mechanisms of treatment response to pirfenidone of idiopathic pulmonary fibrosis (IPF) patients
Source: International Congress 2016 – IPF pathogenesis
Year: 2016
Patients with idiopathic pulmonary fibrosis and chronic obstructive lung disease leak inhaled nanoparticles to the blood.
Source: International Congress 2019 – Involvement of the environment and inflammation in pulmonary remodelling
Year: 2019
Could pulmonary tuberculosis present without any inflammatory response?
Source: Eur Respir J 2005; 26: Suppl. 49, 420s
Year: 2005
Mucosal inflammation in idiopathic bronchiectasis: cellular and molecular mechanisms
Source: Eur Respir J 2008; 31: 396-406
Year: 2008
Is lung emphysema in COPD patients reflected by central airways inflammation?
Source: Eur Respir J 2003; 22: Suppl. 45, 207s
Year: 2003
Oral commensals in the lower airways of COPD leads to an altered host immune tone
Source: Virtual Congress 2020 – Asthma and COPD: How genetic and environment influences its developement?
Year: 2020
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept